"ARDS", an abbreviation for the four giants Abbott, Roche, Danaher and Siemens. Recently, the Big Four also announced the results of the first half of 2016 in the order of ARDS: Abbott was first announced on July 20; followed by Roche on July 22; Danaher chose to announce results on July 25. . Because Siemens will not announce its results until August 4th, for the netizens to interpret the performance of the Big Three, so that everyone can take a quick look, welcome netizens to make a brick. First, the Big Three competed in the first half of the year There is no integration of American Airil in Abbott’s data. There have been rumors that Abbott wants to repent, not to be beautiful. Danaher's data is confusing because of the integration of Pall's data. Pall's revenue in 2015 was around $2.8 billion, and it was close to $1.4 billion in the first half of 2016. Roche's data is relatively stable. Second, what is the diagnostic performance of Abbott? Abbott’s business income for the first half of the year was approximately $2.344 billion, an increase of 6.4% year-on-year. Excluding the impact of the exchange rate, the growth rate was around 3.2%. Among them, the traditional diagnostic business grew steadily, which was the same as the average of the entire diagnostic business of 6.4%. POCT's business growth was impressive, up 10.4%, mainly due to the rapid growth of the i-STAT instrument in the United States and the United States. The molecular diagnostics business grew by 4.6% outside the US, which is good, but in the US it is a negative growth of -0.5%. Abbott’s traditional strengths program, the infectious disease series grew well, while genetic agents were reduced as planned. We should note that the Abbott blood glucose business is divided into the Abbott Medical Devices segment. The total revenue of the blood glucose business was $526 million, of which 142 million were in the United States and 384 million outside the United States. The overall blood glucose business was negative growth of -1.1%, which was mainly affected by the US business, with a negative growth of -26.8%! Although growth outside the US exceeded the double-digit ratio of 13.2%, it was unable to prevent the overall performance from declining.
Food additives refer to chemically synthesized or natural substances added to food in order to improve the quality, color, aroma and taste of food, as well as for the needs of antiseptic and processing technology. Due to the rapid development of the food industry, food additives have become an important part of the modern food industry, and have become an important driving force for technological progress and technological innovation in the food industry. In the use of food additives, in addition to ensuring that they play their due functions and roles, the most important thing is to ensure the safety and hygiene of food.
Our company provides chemical food additives, natural food additives, etc.
Food Additives,Beverage Additives,Malic Acid Powder,Natural Food Additives XI AN RHINE BIOLOGICAL TECHNOLOGY CO.,LTD , https://www.rhinebioteches.com.jpg)
.jpg)
.jpg)
